Search Results - "Poupon, M.F."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance by Cuvier, C, Roblot-Treupel, L, Millot, J M, Lizard, G, Chevillard, S, Manfait, M, Couvreur, P, Poupon, M F

    Published in Biochemical pharmacology (04-08-1992)
    “…We have demonstrated that in vitro resistance of tumor cells to doxorubicin (Dox) can be fully circumvented by using doxorubicin-loaded nanospheres (Dox-NS),…”
    Get more information
    Journal Article
  11. 11

    Reversion of multidrug resistance using nanoparticles in vitro: Influence of the nature of the polymer by Némati, F., Dubernet, C., Fessi, H., Colin de Verdière, A., Poupon, M.F., Puisieux, F., Couvreur, P.

    “…Previous studies have already shown that polyalkylcyanoacrylate nanoparticles were able to overcome multidrug resistance in vitro. The study described in this…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines by DANGLES, V, FEMENIA, F, LAINE, V, BERTHELEMY, M, LE RHUN, D, POUPON, M.-F, LEVY, D, SCHWARTZ-CORNIL, I

    Published in Cancer research (Chicago, Ill.) (15-08-1997)
    “…Human bladder carcinomas often express high levels of the epidermal growth factor (EGF) receptor. In three human bladder carcinoma cell lines (OBR, T24, and…”
    Get full text
    Journal Article
  15. 15

    Methionine deprivation and methionine analogs inhibit cell proliferation and growth of human xenografted gliomas by Poirson-Bichat, F., Lopez, R., Gonçoives, R.A.Bras, Miccohi, L., Bourgeois, Y., Demerseman, P., Poisson, M., Dutrillaux, B., Poupon, M.F.

    Published in Life sciences (1973) (1997)
    “…Growth of numerous malignant tumors depends on an exogenous methionine (MET) supply, while endogenously synthesized MET supports normal cell proliferation…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Adding a Reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts by Arvelo, F., Poupon, M.F., Bichat, F., Grossin, F., Bourgeois, Y., Jacrot, M., Bastian, G., Le Chevalier, T.

    Published in European journal of cancer (1990) (01-10-1995)
    “…Small cell lung carcinomas (SCLC) are characterised by chemosensitivity to diverse antitumoral compounds. However, responses are transitory and relapses are…”
    Get full text
    Journal Article
  18. 18

    Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6 by Prévost, G, Bourgeois, Y, Mormont, C, Lerrant, Y, Veber, N, Poupon, M F, Thomas, F

    Published in Life sciences (1973) (1994)
    “…Human small cell lung cancer (SCLC) is a neuroendocrine tumour with a very poor prognostic. Receptors for somatostatin-14 and its synthetic analogue BIM23014…”
    Get more information
    Journal Article
  19. 19
  20. 20